financetom
Business
financetom
/
Business
/
Alpha Modus Sues Johnson Controls Over AI Patent Claims
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alpha Modus Sues Johnson Controls Over AI Patent Claims
Oct 7, 2025 7:37 AM

10:29 AM EDT, 10/07/2025 (MT Newswires) -- Alpha Modus Holdings ( AMOD ) said its subsidiary filed a patent infringement lawsuit in federal court in Texas against Johnson Controls International ( JCI ) and its Sensormatic Electronics unit.

A separate suit targets Navori of Switzerland and meldCX of Australia, Alpha Modus ( AMOD ) said Tuesday in a statement.

The complaints allege the defendants "are unlawfully deploying Alpha Modus's ( AMOD ) patented artificial intelligence systems that monitor and analyze real-time consumer behavior, sentiment, and product interaction," according to the statement.

Johnson Controls ( JCI ) did not immediately respond to a request for comment from MT Newswires.

Alpha Modus ( AMOD ) shares rose 0.9% in recent Tuesday trading, and Johnson Controls ( JCI ) fell 0.5%.

Price: 1.12, Change: +0.01, Percent Change: +0.90

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Plantro Extends Offer to Buy up to 15% of Information Services Class A Shares
Plantro Extends Offer to Buy up to 15% of Information Services Class A Shares
Apr 8, 2025
08:45 AM EDT, 04/08/2025 (MT Newswires) -- Privately-held Plantro on Tuesday extended to April 28 from April 11 the offer period for its bid to buy up to 2.8 million Class A shares, or 15%, of Information Services (ISC.TO) at an unchanged offer price of $27.25 cash per share. Plantro, which is controlled by Matthew Proud, the former chief executive...
Catalyst Says Health Canada Accepts New Drug Submission for Potential Neuromuscular Disease Treatment
Catalyst Says Health Canada Accepts New Drug Submission for Potential Neuromuscular Disease Treatment
Apr 8, 2025
08:45 AM EDT, 04/08/2025 (MT Newswires) -- Catalyst Pharmaceuticals ( CPRX ) said Tuesday that Health Canada has accepted the new drug submission for AGAMREE submitted by its sublicensee, Kye Pharmaceuticals. The application was granted priority review status, which could accelerate approval before the end of the year. AGAMREE is a treatment intended for Duchenne muscular dystrophy. If accepted, AGAMREE...
CorMedix Sees Q1 Net Sales of $39 Million; Boosts H1 Net Sales Guidance
CorMedix Sees Q1 Net Sales of $39 Million; Boosts H1 Net Sales Guidance
Apr 8, 2025
08:51 AM EDT, 04/08/2025 (MT Newswires) -- CorMedix ( CRMD ) on Tuesday reported preliminary Q1 net sales of $39 million. Analysts polled by FactSet expected $32.3 million. The company raised its H1 net sales guidance to a range of $62 million to $70 million from $50 million to $60 million previously, citing larger-than-expected orders in the last week of...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved